Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Zydus Lifesciences gains after U.S. FDA inspection ends with nil observations

BUZZ-India's Zydus Lifesciences gains after U.S. FDA inspection ends with nil observations

** Shares of India's Zydus Lifesciences ZYDU.NS rise as much as 2.1% to 1,228.60 rupees, stock last up 1.8%

** Stock set for ninth session of gains

** Drugmaker says U.S. FDA inspection of its pharmacovigilance and post-marketing surveillance system at its New Jersey office concluded with nil observations

** Adds inspection was conducted from September 22, 2026 to September 25, 2026

** Stock rated "buy" on average by 29 analysts; median PT is 1,205 rupees - LSEG compiled data

** Stock up 34% YTD



(Reporting by Payel Das in Bengaluru)

((Payel.das@thomsonreuters.com))

Recent news on Zydus Lifesciences

See all news